MedTrace Logo

MRI Brain (Volumetry, fMRI & MRS) in Autism

NCT05758220 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-03-14

No results posted yet for this study

Summary

To reach a feasible method for diagnosing Autism Spectrum Disorder (ASD) outcome measures:

1. Primary (main):

Measurement of various brain structures, including the total brain volume, the volumes of specific brain regions (such as the amygdala, hippocampus, and cerebellum), and the thickness of the cortex.

Detection of other concurrent lesions, e.g. tuberous sclerosis
2. Secondary (subsidiary):

levels of various neurotransmitters, such as glutamate and GABA, and other metabolites, such as N-acetyl aspartate (NAA), in specific regions of the brain Assessing neural activity and connectivity in the brain in the resting state

Conditions

Interventions

DEVICE

MRI

Structural MRI volumetry, resting functional MRI \& MR spectroscopy

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mohamed ab AbdelTawab, MD · Assiut University

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-04-30
Completion
2025-05-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05758220 on ClinicalTrials.gov